Show simple item record

dc.contributor.authorRichmond, JP
dc.contributor.authorKelly, MG
dc.contributor.authorJohnston, A
dc.contributor.authorMurphy, PJ
dc.contributor.authorMurphy, AW
dc.date.accessioned2021-09-21T04:36:18Z
dc.date.available2021-09-21T04:36:18Z
dc.date.issued2021
dc.identifier.issn1462-3889en_US
dc.identifier.doi10.1016/j.ejon.2021.102015en_US
dc.identifier.urihttp://hdl.handle.net/10072/408169
dc.description.abstractPurpose: Oral anti-cancer medication (OAM) has revolutionised oncology care. Due to their potential toxicities and associated safety challenges ongoing assessment and monitoring is essential; currently generally performed in acute care settings. Internationally there exists a transformative vision to shift patient care from acute to primary care. A nurse-led integrated model of care could be developed for OAM patient management in primary care. The aim of this study was to examine international literature regarding current clinical management practices for assessment and monitoring of patients receiving OAM. Methods: Following PRISMA-ScR guidelines, databases MEDLINE, CINAHL and Web of Science were searched for English studies published between 2010 and 2020 using keywords: assessment, cancer, care, management, oral anticancer medications. Articles were screened and assessed for eligibility. From eligible studies, data were extracted to summarize, collate and make a narrative account of the findings. Results: 2261 papers were reviewed, 14 met inclusion criteria. Three phases of management are reported: 1. Patient treatment plan development; 2. Patient education; 3. Patient monitoring. Within these phases seven specific stages of care were identified broadly representing the patient's journey: (1) treatment decision, (2) prescribing of OAM, (3) OAM dispensing and administration, (4) maximising patient safety (5) ongoing patient assessment (6) patient support (7) communication with other health-care professionals. Conclusions: Despite a paucity of international literature, a dedicated OAM clinic was endorsed as a means to achieve improved care. Nurses and pharmacists were identified as being of particular importance especially in education and ongoing management of patients receiving OAMs.en_US
dc.description.peerreviewedYesen_US
dc.languageenen_US
dc.publisherElsevier BVen_US
dc.relation.ispartofpagefrom102015en_US
dc.relation.ispartofjournalEuropean Journal of Oncology Nursingen_US
dc.relation.ispartofvolume54en_US
dc.subject.fieldofresearchNursingen_US
dc.subject.fieldofresearchOncology and carcinogenesisen_US
dc.subject.fieldofresearchClinical pharmacology and therapeuticsen_US
dc.subject.fieldofresearchcode4205en_US
dc.subject.fieldofresearchcode3211en_US
dc.subject.fieldofresearchcode321402en_US
dc.titleCurrent management of adults receiving oral anti-cancer medications: A scoping reviewen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationRichmond, JP; Kelly, MG; Johnston, A; Murphy, PJ; Murphy, AW, Current management of adults receiving oral anti-cancer medications: A scoping review, European Journal of Oncology Nursing, 2021, 54, pp. 102015en_US
dc.date.updated2021-09-21T04:34:36Z
gro.hasfulltextNo Full Text
gro.griffith.authorJohnston, Amy N.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record